1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

12 Mar 2024
Admin
News Article

Sukino Healthcare Gets NABH Certification

Sukino Healthcare Solutions secures NABH certification for continuum care centre

Overview

Sukino Healthcare Solutions, a leading continuum care provider, has received the NABH (National Accreditation Board for Hospitals & Healthcare Providers) certification for one of its continuum care centres. The accreditation according to the company is in recognition of its patient-centric model, adhering to stringent compliances, and ensuring exceptional quality in healthcare services.

Word from CEO: Sukino

Rajinish Menon, CEO & founder, Sukino Healthcare Solutions, said, “Accreditation from NABH is a crucial validation of the excellence of our services. It’s like a badge that says that we follow the best standards and that we are transparent and accountable to these. When organisations such as ours get recognised internationally, we are able to strengthen the city healthcare ecosystem and secure the trust of the community.”
The company said that it has consistently prioritised patient well-being and safety. The NABH accreditation, that comes for Sukino’s continuum care centre in Whitefield, Bengaluru, reinforcing its emphasis on quality management systems, infection control practices, patient rights, and overall clinical governance.
“Post NABH accreditation, patients are the ultimate beneficiaries, experiencing heightened care quality, and safety, which perfectly aligns with the Sukino model of care delivery. Looking forward, we aim to equip our continuum care centres with more facilities and personnel. By focusing on patient satisfaction, we intend to enhance the overall healthcare experience,” added Menon.

Sukino’s Revolutionary Work

Sukino Healthcare, with nine continuum care centres, has been revolutionising post-hospital care in Bengaluru, Thriuvananthapuram, and Kochi. Its tech and standard care offer 24/7 support, private rooms, and medical services. Skilled nurses, physiotherapists, and acute care services optimise recovery; personalised support is provided in its rehab services for patients with cancer and neural disorders and dementia care for memory loss patients.

Funding Raised by Sukino

Earlier, Sukino Healthcare Solutions had raised Rs. 50 crore in Series A funding from Stakeboat Capital.
The company is backed and mentored by Kris Gopalakrishnan, co-founder, Infosys, and TV Mohandas Pai, chairman, Aarin Capital, Sukino is certified by NABH and has a strong presence in Benglauru and Kochi.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!